Why are we dragging our feet when more automation in health care will save lives?
In planes, trains and cars, we increasingly entrust our lives to automated safety systems. It's time for medical technology to catch up.
Academic rigour, journalistic flair
Articles on FDA
Displaying 1 - 20 of 28 articles
Don’t believe everything you hear about pesticides on fruits and vegetables
Reports about trace amounts of pesticides, like the EWG's Dirty Dozen, can leave people afraid to buy fruits and vegetables. But the hype is often overblown.
Faster access to new drugs doesn’t always mean better treatment
Intuitively, it might seem desirable to speed up access to medicines. But this means more drugs will be approved that may subsequently prove unsafe or ineffective.
How man’s best friend is helping cancer treatment
Dogs are great companions, and they also are proving to be great research subjects for cancer. Here's how our canine friends are pointing to possible treatments in human cancer.
Faster approval for drugs and medical devices under the 21st Century Cures Act raises concerns for patient safety
Lowering the threshold for FDA approval and feeding the agency less rigorous information will increase the likelihood of approvals of unsafe or ineffective drugs and devices.
Why are young women without wrinkles using Botox?
By getting young women hooked before they've even formed wrinkles, Botox peddlers have realized they can enlist them in a lifetime of treatment.
Multiple sclerosis survivors swear by hyperbaric oxygen – but does it work?
There is conflicting medical evidence.
The real reason the EpiPen and other off-patents are so expensive
The maker of the EpiPen has raised the price of two injectable treatments to about US$600, six times the price nine years ago. Why do drug companies do this? Because they can. The FDA ends up helping.
Why public health worries don’t have to ruin your cookie dough
The FDA recently advised people not to eat raw cookie dough because raw flour with E. coli in it had sickened 38 people. Do we really have to forgo our favorites?
Could FDA e-cigarette regulations help more people quit smoking?
Federal officials could give the FDA authority to develop e-cigarette regulations. But developing regulations that maximize their benefits and minimize their risks is harder than it looks.
Infographic: a snapshot of the thalidomide tragedy
Thalidomide was marketed as a safe, sleep-inducing drug, but when taken during pregnancy it could cause severe birth defects.
Timeline: key events in the history of thalidomide
Documents reveal thalidomide's manufacturer was warned about possible harms as early as 1956.
Why biologics were such a big deal in the Trans Pacific Partnership
Before the last round of negotiations, only a handful of issues remained in the way of concluding the TPP. A potential deal-breaker for Australia was intellectual property protections for biologics.
Antidepressant trial’s upended results show need for sharing all data
As part of an intiative to re-examine misrepresented or abandoned studies, we re-analysed an antidepressant trial. Here's what we found.
Victoria needs other states’ help for powdered alcohol ban to work
The Victorian government is calling on other state governments to join it in banning powdered alcohol, which was recently approved for marketing and sale in the US.
Should dying patients have the right to access experimental treatments?
In the last six months Colorado, Louisiana, Missouri, Michigan and, most recently, Arizona have passed “right to try” laws that allow terminally ill patients to access treatments that have only passed…
‘Right to try’ laws are compassionate, but misguided
On November 4, the state of Arizona will decide whether to join Colorado, Missouri, Louisiana and Michigan in passing so-called right to try laws. If passed, the “Arizona Terminal Patients’ Right To Try…
How the Dallas Buyers Club changed HIV treatment in the US
This article contains spoilers. In the award-winning movie The Dallas Buyers Club, Matthew McConaughey plays the role of Ron Woodroof, a real-life Texas cowboy who was diagnosed with HIV/AIDS in 1985…
Why there may be fewer truly new drugs hitting the market
Developing new drugs is hard and expensive. The lengthy process from initial discovery to the market is some times compared…
Public misinformed about seal of approval from US drug agency
Between 2005 and 2011, nearly half of all new drug formulations in the US were approved without companies having to demonstrate a tangible benefit, such as relieving disease symptoms, extending life, or…
Top contributors
-
Postdoctoral research fellow, University of Adelaide
-
Research Leader, Critical and Ethical Mental Health research group, Robinson Research Institute, University of Adelaide
-
Senior lecturer in Pharmacology, University of Adelaide
-
Professor and Head of Clinical Research, National Centre for Immunisation Research and Surveillance, University of Sydney
-
Senior Research Fellow, WHO Collaborating Centre for Obesity Prevention, Deakin University
-
Senior Research Fellow, Bioethics, University of Sydney
-
Associate Professor Politics and Policy Studies, Deakin University
-
PhD candidate, University of Sydney
-
Professor of Medicine, University of Sydney
-
Research fellow, University of Sydney
-
Emeritus Professor of Clinical Sciences, University of Bristol
-
Nial Wheate is a Friend of The Conversation.
BPharm Coordinator and Senior Lecturer, University of Sydney
-
Ontario Research Chair in Bioethics and Public Policy, Queen's University, Ontario
-
Assistant Professor in Human Genetics, Cold Spring Harbour Laboratory
-
Research Professor of Epidemiology, Emory University
Most read on The Conversation
Credit card fraud: what you need to know
Teaching little girls to lead
For Pakistan, China’s huge energy investments may have serious political costs
New Delhi is running out of water
Global hijabista style, from the Afghan burqa to the cover of a fashion magazine
As another smog season looms, India must act soon to keep Delhi from gasping
The Islamic State is on its knees, but its legacy will long haunt the Middle East
Now is the summer of our discontent: memes, national identity and the globalisation of rage
These three firms own corporate America